|
On (b)(6) 2026, abbott point of care was contacted by a customer regarding i-stat act kaolin cartridges that yielded a discrepant results on a 51-year-old male patient with atrial fibrillation.There was no additional patient information available.Return product is not available for investigation.Date : tested result: heparin time: on (b)(6) 2026, 16000, 9:44, (b)(6) 2026, 10:00, >1000, (b)(6) 2026, 10:27, 286 , (b)(6) 2026, 10:27, 276 , (b)(6) 2026 , 3000 , 10:30.At this time there is no reason to suspect a malfunction exists.The reporting decision was based on the limited information available that suggests the product was not performing within the variability of the assay.An investigation is underway.Per i-stat system manual (art: 714185-00q), the i-stat kaolin activated clotting time (kaolin act) test is an in vitro diagnostic test that uses fresh, whole blood.And is used to monitor high-dose heparin anticoagulation frequently associated with cardiovascular surgery.
|
|
Apoc incident: # (b)(4).The customer reported unexpected results when testing cartridges from act kaolin cartridge lot# r25236.The customer returned lot# r25326 for investigation.Although both lots had been used at the facility, based on event date, lot# r25326 would be the lot in use at the time of the event.Lot# r25236 would have been expired.The investigation was completed on 06-may-2026.A review of the device history records (dhr) confirmed the cartridge lot passed release specifications.Retained and returned cartridge testing met the acceptance criteria in appendix 1 of q04.01.003 rev.Ap (product complaint level 2 and level 3 investigation procedure).No deficiency has been identified for lot# r25326.(refer to d4 & h4 for corrected information).
|